Intravenous Iron In Ambulant Patients With Heart Failure – Do We See The Same Benefits?

Intravenenous Iron
Iron deficiency is present in 50% of the patients with heart failure and it is associated with worse symptoms and outcomes [1]. There have been a few studies analysing the benefit of intravenous (IV) ferric carboxymaltose in heart failure with iron deficiency. In the AFFIRM-AHF [2] trial, administration of IV ferric carboxymaltose reduced the risk of cardiovascular death and total hospitalisations for heart failure in patients hospitalized for acute heart failure.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Dr Ben Ng Understanding Hypothyroidism and Hyperthyroidism
Understanding Hypothyroidism and Hyperthyroidism

The thyroid, a butterfly-shaped gland in the neck, is the unsung hero of our endocrine system. Producing hormones that regulate numerous metabolic processes in the body it can sometimes malfunction in one of two ways: it produces too little (hypothyroidism) or too much (hyperthyroidism) of the hormone. Medical Channel Asia invites Dr Ben Ng, Consultant Endocrinologist at Arden Endocrinology Specialist Clinic Mount Elizabeth Novena, to provide key insights into this condition.

Read More »